Zobrazeno 1 - 10
of 43
pro vyhledávání: '"P.A. Farling"'
Publikováno v:
Anaesthesia. 58:358-362
The use of remifentanil has been recommended because of its ability to minimise the hypertensive response to tracheal intubation and surgical stimulation in various types of surgery. We describe the use of remifentanil in the anaesthetic management o
Autor:
P.A. Farling, S. Gillespie
Publikováno v:
British Journal of Anaesthesia. 93:758-760
Autor:
P.A. Farling, A.K. Durairaju
Publikováno v:
British journal of anaesthesia. 92(6)
Carcinoid syndrome creates many challenges during anaesthesia, including hypertension, hypotension and bronchospasm. These challenges are less common and less severe after the routine use of octreotide. We describe the use of remifentanil as part of
Autor:
P.A. Farling, R. Haughey
Publikováno v:
British Journal of Anaesthesia. 109:132-133
Autor:
P.A. Farling
Publikováno v:
British journal of anaesthesia. 85(1)
In summary, disease of the thyroid gland is common. Anaesthetists will be required to manage patients with hypothyroidism and hyperthyroidism and those requiring thyroidectomy. Since anaesthesia for thyroidectomy provides many challenges of airway ma
Autor:
P.A. Farling
Publikováno v:
British Journal of Anaesthesia. 107:824
Autor:
P.A. Farling, H. A. Aitken
Publikováno v:
Anaesthesia. 46(4)
Autor:
A. Hope, P.A. Farling
Publikováno v:
Anaesthesia. 45(8)
Publikováno v:
Anaesthesia. 45(7)
Publikováno v:
British Journal of Anaesthesia. 78:90-91
We have studied the onset and duration of action of rocuronium 0.6 mg kg-1 in patients receiving therapy for more than 1 month with beta-receptor blocking drugs (n = 16), calcium entry blocking drugs (n = 17) or anticonvulsant drugs (n = 14) and comp